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Abstract
Background: Classical bioconjugation strategies for generating antibody-functionalized
nanoparticles are non-specific and typically result in heterogeneous compounds that can be
compromised in activity. Expression systems based on self-cleavable intein domains allow the
generation of recombinant proteins with a C-terminal thioester, providing a unique handle for site-
specific conjugation using native chemical ligation (NCL). However, current methods to generate
antibody fragments with C-terminal thioesters require cumbersome refolding procedures,
effectively preventing application of NCL for antibody-mediated targeting and molecular imaging.
Results: Targeting to the periplasm of E. coli allowed efficient production of correctly-folded
single-domain antibody (sdAb)-intein fusions proteins. On column purification and 2-
mercapthoethanesulfonic acid (MESNA)-induced cleavage yielded single-domain antibodies with a
reactive C-terminal MESNA thioester in good yields. These thioester-functionalized single-domain
antibodies allowed synthesis of immunomicelles via native chemical ligation in a single step.
Conclusion: A novel procedure was developed to obtain soluble, well-folded single-domain
antibodies with reactive C-terminal thioesters in good yields. These proteins are promising building
blocks for the chemoselective functionalization via NCL of a broad range of nanoparticle scaffolds,
including micelles, liposomes and dendrimers.
Background
The ability to raise antibodies with high affinity and spe-
cificity to almost any biomolecular target has made anti-
bodies essential components in many biomedical fields,
both in diagnostics and in the active targeting of drugs
and contrast agents for molecular imaging [1]. For many
of these applications there has been a drive to move
towards smaller antibody formats, both to allow efficient
recombinant production in E. coli and to potentially avoid
unwanted immunogenic problems [2]. The ability to
express these smaller antibody fragments in E. coli has also
allowed the application of phage display approaches to
allow in vitro screening of large libraries of antibody frag-
ments. Nowadays, a wide range of smaller antibody for-
mats are available including monovalent antibody
fragments (Fab), single-chain antibody fragments (scFv),
and single-domain antibodies (sdAb) [3]. The latter,
which are sometimes also referred to as nanobodies, are
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derived from heavy-chain-only antibodies that have been
found in camels, dromedaries, llamas and sharks [3,4].
Single-domain antibodies are the smallest antibody frag-
ments available to date and have unique features includ-
ing high solubility and thermal stability [4].
Current methods for bioconjugation of antibody frag-
ments are non-specific and usually rely on amine and
cysteine functionalities present on the protein surface [5].
This lack of control over the conjugation reaction gives
rise to heterogeneous protein-nanoparticles. Moreover,
the smaller size of single-domain antibodies compared to
full size antibodies significantly increases the risk of
affecting key residues near the antigen binding site when
using non-specific conjugation strategies. In recent years
several bioorthogonal ligation reactions that were origi-
nally developed in peptide chemistry have been applied
for chemoselective protein functionalization of nanopar-
ticles and chip surfaces [6-14]. Two examples of antibody
conjugation using oxime chemistry were recently reported
that take advantage of novel methods to selectively oxi-
dize the N-terminus of antibodies or introduce geneti-
cally-encoded aldehyde tags at any position in the
antibody sequence [15,16]. While promising, the applica-
bility of oxime chemistry is still hampered by the incom-
plete introduction of ketone functionalities and the
inability to use N-terminal acetylated proteins [17,18].
We and others have therefore explored the use of native
chemical ligation (NCL) as an alternative chemoselective
conjugation reaction, demonstrating its potential for the
ligation of proteins to chip surfaces, dendrimers, sup-
ported lipid bilayers, micelles and liposomes [6,11,12,19-
23]. Native chemical ligation is a chemoselective reaction
under aqueous conditions between a C-terminal thioester
and an N-terminal cysteine yielding a native peptide bond
[24]. Site-specific coupling via NCL was made possible by
the development of expression systems with self-cleavable
intein domains to generate recombinant proteins with C-
terminal thioesters [25].
Intein fusion proteins are normally expressed in the cyto-
plasm of E. coli, a reducing environment that prevents the
proper formation of disulfide bonds that are essential for
antibody stability. In vitro refolding of scFv-intein fusion
proteins followed by on-column NCL has been reported
[26], but the requirement to perform NCL on the column
limits the applicability of this method. We recently
reported a refolding procedure based on the redox couple
sodium 2-mercaptoethanesulfonate (MESNA)/sodium
2,2-dithio-bis(ethanesulfonate) (diMESNA) to generate
disulfide-containing proteins with a C-terminal MESNA
thioester [27]. However, also for this method the require-
ment to do in-vitro refolding presents an important prac-
tical limitation. Here, we present an efficient strategy to
obtain well-folded single-domain antibodies with a reac-
tive C-terminal thioester by targeting the intein fusion
protein to the periplasm of E. coli. Targeting antibody frag-
ments to the oxidizing environment of the bacterial peri-
plasm is known to increase the amount of active antibody
fragments by allowing proper disulfide bond formation.
Following this new procedure single-domain antibodies
with C-terminal thioesters are obtained that can be
directly coupled to cysteine-functionalized micelles to
generate immunomicelles via native chemical ligation.
Results and discussion
Production of single-domain antibodies with a C-terminal 
thioester
Our approach, schematically depicted in Figure 1, was
tested using a llama single-domain antibody obtained
from screening a phage display library against glutath-
ione-S from Schistosoma japonicum. The DNA sequence
encoding for this antibody domain (sdAb-aGST) was pro-
vided in the pHENIX vector which contains an N-terminal
sequence encoding a periplasmic leader sequence (pelB)
and C-terminally a vesicular stomatitis virus (VSV-G) tag
for detection purposes (see Additional file 1) [28]. The
pelB leader sequence was used to target the protein to the
oxidizing environment of the periplasm, because the
sdAb-aGST protein contains a conserved disulfide bond
that is known to be important for the stability of these sin-
gle domain antibodies [29]. Since transport of the fusion
protein to the periplasm could be dependent on the
nature of the intein, we tested two commercially available
intein expression vectors, pTXB1 and pTYB1 (NEB), that
differ in the nature of the intein domain. The target gene
was cloned at the N-terminus of the inteins while a chitin-
binding domain (CBD) was present at the C-terminus of
the intein for purification purposes. Both expression vec-
tors were transformed into E. coli BL21 (DE3) and expres-
sion was assayed under a variety of conditions. SDS-PAGE
analysis showed that expression using the pTXB1 vector
allowed efficient transport of the intein fusion protein to
the periplasm of E. coli, as evidenced by a band of 45 kDa
in the periplasmic fraction (Figure 2). In contrast, expres-
sion of the single-domain antibody using the pTYB1 vec-
tor resulted in accumulation of the fusion protein as an
insoluble aggregate in the cytoplasm of E. coli (not
shown).
Figure 2 shows the purification of the MESNA thioester of
sdAb-aGST (sdAb-aGST-MESNA) starting form the peri-
plasmic fraction containing the sdAb-aGST-intein-CBD
fusion protein. Upon loading the periplasmic fraction on
a chitin column the sdAb-aGST-intein-CBD fusion pro-
tein binds to the chitin resin. The single-domain antibody
with a C-terminal MESNA thioester was eluted from the
chitin column after overnight incubation with the thiol
MESNA. Yields for thioester terminated single-domain
antibodies varied between 2 – 5 mg/L, which compares
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favorably with the 0.1–6 mg/L yields typically reported for
single-domain antibodies via periplasmic expression in E.
coli [30]. Since SDS-PAGE analysis showed the presence
of two bands of slightly different molecular weight
around 18 kDa, we performed LC-MS analysis to charac-
terize the obtained proteins (Figure 2B). The main peak at
5.5 min contained sdAb-aGST-MESNA with the pelB
leader attached (pelB). This peak also contained sdAb-
aGST-MESNA with the first amino acid of the pelB leader
removed (pelBΔ1). The minor peak at 5 min contained
two sdAb-aGST-MESNA protein species with the first 14
and 15 amino acids of the pelB leader removed. The dou-
ble band visible on the SDS-PAGE gel thus corresponds to
multiple species of sdAb-aGST, all of which contain a C-
terminal MESNA thioester. Addition of protease inhibi-
tors during the purification procedure could not prevent
this heterogeneous N-terminal processing. Similar incom-
plete pelB removal was observed before in E. coli
BL21(DE3) strains and has been suggested to be due to
the inability of its amino peptidase to efficiently cleave the
pelB leader peptide [31]. The minor band observed on the
SDS-PAGE gel around 70 kDa was identified using LC-MS
as DnaK, a molecular chaperone protein that prevents
aggregation of misfolded proteins in E. coli.
The sdAb-aGST protein contains a single disulfide bond
that has previously been shown to play an essential role in
the stability of these single-domain antibodies. To estab-
lish whether the reducing conditions used during MESNA
cleavage affected the sdAb-aGST-MESNA produced in this
manner, its interaction with GST was studied using Sur-
face Plasmon Resonance (SPR). Initial attempts to immo-
bilize the sdAb-aGST-MESNA to the CM5 Biacore chip
using a standard amine coupling procedure resulted in a
complete loss of GST binding capacity, suggesting that
this classical amine coupling affects residues critical for
antigen binding. The sdAb-aGST-MESNA protein contains
11 lysine residues, two of which are indeed located near
the antigen binding site. To exclude antibody deactivation
the assay was reversed and GST was immobilized on the
CM5 chip. Figure 3A shows a clear binding response of the
sdAb-aGST-MESNA to GST with an apparent dissociation
constant of 120 nM. This number is in good agreement
with results from an ELISA assay, which showed a dissoci-
ation constant of 80 nM (Figure 3B). The observed disso-
ciation constants for the sdAb-aGST are similar to those
reported for other single-domain antibodies [32]. In addi-
tion, SPR analysis of sdAb-aGST-MESNA after NCL with
cysteine (sdAb-aGST-Cys) showed binding behavior that
was similar to that of untreated sdAb-aGST (see Addi-
tional file 1). So while we cannot exclude at this time that
the disulfide bond becomes transiently reduced during
MESNA treatment or NCL, these procedures did not irre-
versibly affect the functionality of sdAb-GST.
Preparation of immunomicelles with single-domain 
antibodies using NCL
To test the performance of sdAb-aGST-MESNA in NCL
reactions, we first assessed its reactivity towards cysteine-
functionalized biotin. Ligation of this small molecule can
Flow chart showing the approach explored in this workigure 1
Flow chart showing the approach explored in this work. Introduction of a pelB leader sequence targets the sdAb-
intein-CBD fusion protein to the periplasm, where the presence of disulfide isomerases and an oxidizing environment ensure 
proper folding and disulfide bond formation of the antibody domain. The chitin binding domain (CBD) allows single-step purifi-
cation of the fusion protein from the periplasm, where after on-column treatment with MESNA results in intein-mediated 
cleavage and the formation of single-domain antibody with a reactive C-terminal thioester, which can then be directly applied in 
subsequent native chemical ligation reactions.
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Characterization of the single-domain antibody purification using SDS-PAGE and LC-MSFigure 2
Characterization of the single-domain antibody purification using SDS-PAGE and LC-MS. (A) Expression and 
purification of the sdAb-aGST as intein fusion protein and subsequent generation of the C-terminal MESNA thioester via chitin 
affinity chromatography and intein mediated cleavage. (B) LC-MS analysis of the elution fraction of the chitin column. Top left 
panel: chromatogram; Top right and bottom panels: deconvoluted mass spectra of peaks 1, 2 and 3. (pelB: sdAb-aGST-MESNA 
with pelB leader attached (calcd. mass 19632 Da);pelBΔ1: sdAb-aGST-MESNA with the first amino acid of the pelB leader 
removed (calcd. mass 19501 Da); pelBΔ14: sdAb-aGST-MESNA with the first 14 amino acid of the pelB leader removed 
(calcd. mass 18175 Da); pelBΔ15: sdAb-aGST-MESNA with the first 15 amino acid of the pelB leader removed (calcd. mass 
18062 Da); DnaK (calc. mass 68983 Da)).
The binding of the sdAb-aGST-MESNA to GST assayed with SPR and ELISAFigure 3
The binding of the sdAb-aGST-MESNA to GST assayed with SPR and ELISA. (A) SPR analysis of sdAb-aGST-
MESNA binding to GST. Insert: steady state responses were plotted against the concentration. The line represents a fit to a 
one-site binding model using a KD of 116 nM. (B) ELISA measurement of binding of sdAb-aGST to GST (square) fitted with a 
one-site binding model using a KD of 77 nM and BSA (circle).
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be conveniently monitored using LC-MS. In addition, sin-
gle-domain antibodies with C-terminal biotin groups are
attractive for use in combination with the many streptavi-
din-modified compounds that are now commercially
available. Figure 4 shows the LC-MS analysis of the prod-
uct obtained after reaction of sdAb-aGST-MESNA with an
excess of cysteine-functionalized biotin overnight at room
temperature. Again two peaks appear in the chromato-
gram corresponding to sdAb-aGST with various fragments
of the pelB leader sequence still attached. All peaks corre-
spond to biotinylated forms of sdAb-aGST, with the
exception of a minor peak at 19635 Da corresponding to
a small amount of unreacted sdAb-aGST-MESNA.
Having established the essentially complete biotinylation
of sdAb-aGST-MESNA, we next used the sdAb-aGST-
MESNA to prepare immunomicelles [22,23]. Pegylated
phospholipids such as PEG2000-DSPE are known to form
relatively stable micelles with a critical micelle concentra-
tion (CMC) of ~5 μM, forming micelles with a diameter
of 13 nm and approximately 90 lipids per micelle [33]. By
attaching cysteine-functionalities at the end of the PEG-
chain (Cys-PEG2000-DSPE) we recently showed that
these micelles can be readily functionalized with up to 20
copies of the collagen binding protein CNA35 equipped
with a C-terminal thioester. Here we used the same proce-
dure to prepare micelles functionalized with sdAb-aGST.
Micelles were prepared by mixing cysteine-functionalized
phospholipids (Cys-PEG2000-DSPE) and rhodamine
phospholipids in a 40:1 ratio, followed by addition of
sdAb-aGST-MESNA in a 1:11 protein-lipid ratio. SDS-
PAGE analysis showed essentially complete conversion to
the lipidated form after overnight incubation with 50 mM
4-(carboxylmethyl) thiophenol (MPAA) (Figure 5A).
Based on the aggregation number of 90 lipids per micelle
and the full conversion of the sdAb-aGST to the lipidated
form, one can calculate that the micelles contained on
average eight sdAb-aGST proteins and two rhodamines. A
solid-phase binding assay shows specific binding of the
sdAb-aGST functionalized micelles to GST with half max-
imal binding at 14 μM PEG2000-DSPE. Since no binding
was observed for non-functionalized micelles, and
because the rhodamine-lipid is associated with the
micelle via non-covalent interactions, this assay provides
direct evidence for the specific binding of intact immu-
nomicelles. It is important to note that the apparent dis-
sociation constant of ~14 μM is based on the lipid
concentration and reflects the stability of the micelles and
not the intrinsic affinity of the sdAb domains attached to
the micelles. A similar phenomenon was observed previ-
ously for the binding of CNA35-functionalized micelles
to collagen, which also showed half maximal binding at a
lipid concentration of ~10 μM, despite the fact that
CNA35 by itself binds collagen with 0.5 μM affinity [23].
Chromatogram and deconvoluted mass spectrum of the biotinyl ed single- omain antibo y against GST after over-n ght ligationFi ure 4
Chromatogram and deconvoluted mass spectrum of 
the biotinylated single-domain antibody against GST 
after overnight ligation. pelB-biotin: biotinylated sdAb-
aGST with pelB leader attached (calcd. mass 19879 Da); 
pelB: MESNA thioester of the sdAb-aGST with pelB leader 
attached (calcd. mass 19632 Da); pelBΔ3-biotin: bioti-
nylated sdAb-aGST with the first three amino acids of the 
pelB leader removed (calcd. mass 19457 Da);); pelBΔ14-
biotin: biotinylated sdAb-aGST with the first 14 amino acids 
of the pelB leader removed (calcd. mass 18423 
Da);pelBΔ15-biotin: biotinylated sdAb-aGST with the first 
15 amino acids of the pelB leader removed (calcd. mass 
18309 Da); pelBΔ16-biotin: biotinylated sdAb-aGST with 
the first 16 amino acids of the pelB leader removed (calcd. 
mass 18238 Da);
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Conclusion
An efficient strategy was developed that generates active,
folded single-domain antibodies with a reactive C-termi-
nal thioester for direct application in nanoparticle func-
tionalization via native chemical ligation. Two
applications were reported here to illustrate their poten-
tial as generic building blocks for the generation of tar-
geted nanoparticles, the generation of biotinylated single-
domain antibodies and the efficient preparation of immu-
nomicelles. Finally, the approach of targeting intein
fusion proteins to the bacterial periplasm may provide a
generic, attractive alternative to existing methods to
obtain disulfide-containing proteins with a C-terminal
thioester.
Methods
General
Unless stated otherwise, all reagents and chemicals were
obtained from commercial sources and used without fur-
ther purification. Cysteine-functionalized 1,2-Distearoyl-
sn-glycero-3-phosphoethanolamine-N-[amino(poly(eth-
ylene glycol))2000] (Cys-PEG-DSPE) was prepared
according to a literature procedure [22]. The expression
vectors pTXB1 and pTYB1, restriction enzymes and chitin
beads were purchased from New England Biolabs (Bev-
erly, MA). Competent cells were purchased from Novagen
(Darmstadt, Germany). Monoclonal mouse anti-vsv glyc-
oprotein antibody (V5507) was purchased from Sigma
(St. Louis, MO). HRP-conjugated rabbit anti-mouse
immunoglobulin polyclonal antibody (P0260) was pur-
chased from DakoCytomation (Heverlee, The Nether-
lands). UV-Vis spectra were recorded on a Shimadzu
Multispec 1501 spectrophotometer. Primers used for all
the cloning procedures were supplied by MWG (Ebers-
berg, Germany).
Plasmid constructs
The GST-specific single-domain antibody was obtained
from a naïve llama-derived nanobody library described
previously [34]. Selection of phages for binding to bacte-
rial expressed recombinant GST (pGEX-4T-2 vector) was
performed essentially as described in [35,36]. The gene
encoding for sdAb-aGST was amplified by PCR from vec-
tor pHENIX sdAb-α GST C11 with the primer pair
pUC119pelB_f (5'-GGTGGTCATATGAAATACCTATT-
GCCTACGGCAGC-3') and pUC119vsv_r (5'-GGTGGTT-
GCTCTTCCGCATGCGGCCCCCTTTCCAAG-3'). The PCR
products and the pTXB1 and pTYB1 vectors were double-
digested with the restriction endonucleases Nde I and Sap
I followed by ligation of the amplified DNA fragments in
the open plasmids yielding the expression plasmids
pTXB1-sdAb-aGST and pTYB1-sdAb-aGST. DNA sequenc-
ing (BaseClear, Leiden, The Netherlands) using T7 pro-
moter and intein-specific reversed primers (New England
Preparation and activity analysis of single-domain antibody micellesFigure 5
Preparation and activity analysis of single-domain antibody micelles. (A) SDS-PAGE analysis of NCL of 626 μM Cys-
PEG-DSPE with 50 μM sdAb-aGST-MESNA. The reaction was performed overnight at room temperature in buffer containing 
100 mM sodium phosphate, 50 mM MPAA, 10 mM TCEP, pH 6. (B) Solid-phase binding assay of sdAb-aGST functionalized 
micelles to GST (squares). Micelle binding was monitored by measuring the fluorescence of the rhodamine lipids at 620 nm 
using an excitation of 578 nm. Control experiments using non-modified micelles incubated on GST (triangles) and sdAb-aGST 
functionalized micelles on milk powder coated plates (diamonds) are also shown for comparison. The solid line represents a fit 
to a 1:1 binding model using an apparent Kd of 14 μM.
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Biolabs) confirmed the correct in-frame fusion of the pro-
teins with the intein sequence.
Protein Expression and Purification
The expression plasmids were transformed into E. coli
BL21 (DE3) cells. Expression experiments were performed
in 0.5 L LB cultures supplemented with 100 μg/mL ampi-
cillin by inoculating with a 5 mL overnight culture. The
cultures were grown at 37°C and 250 rpm until the OD600
reached a value between 0.5–0.6. Protein expression was
induced with 0.2 mM IPTG and cultures were incubated
for 3 hours at 30°C. Cells were harvested by centrifuga-
tion for 10 min at 8,000 g at 4°C, after which the medium
was discarded and the cell pellets were resuspended in 85
mL TES (30 mM Tris-HCl pH 8.0, 1 mM EDTA, 20% (w/
v) sucrose) and incubated at room temperature for 10
minutes with continuous shaking. After centrifugation for
10 min at 8,000 g and 4°C, the pellet was resuspended in
85 mL of ice-cold 5 mM MgSO4 and incubated on ice for
10 minutes with occasional shaking. After centrifugation
for 10 min at 8,000 g at 4°C, 2 mL 0.5 M Tris-HCl pH 7.5
was added to the supernatant. ATP (3 mM) was added to
the supernatant and incubated for 1–3 hours at 4°C to
suppress binding of DnaK to the sdAb-aGST intein fusion
protein. The periplasmic protein fraction was directly
applied to a chitin column that was equilibrated with 10
column volumes of column buffer (20 mM sodium phos-
phate, 0.1 mM EDTA, 0.5 M NaCl, 3 mM ATP, pH 8). The
column was washed with 10 volumes of column buffer
after which the columns were quickly flushed with 3 col-
umn volumes of cleavage buffer (20 mM sodium phos-
phate, 0.1 mM EDTA, 0.5 M NaCl, 100 mM MESNA, pH
6) and incubated overnight at 4°C. Proteins were eluted
in cleavage buffer without MESNA and pooled. The pro-
tein concentration was determined by UV-Vis using ε280
nm = 24,535 M-1cm-1 or using a Quant-it protein assay
(Invitrogen) according to the manufacturers instructions.
LC-MS
Samples for LC-MS analysis were concentrated with
Biomax centrifugation filters (MWCO 5 kDa) for small
volumes and Amicon centrifugational filters (MWCO 10
kDa) for large volumes. Samples were buffer exchanged to
a mixture of 9:1 H2O/acetonitrile or to 50 mM ammo-
nium acetate pH 6.8. Reversed phase HPLC was per-
formed on a Vydac protein column with a mobile phase
of H2O/acetonitrile with 0.1% TFA. ESI-MS spectra were
measured on a Thermo Finnigan LCQ Deca XP MAX in
positive mode. MagTran software was used for deconvolu-
tion.
ELISA
All washing steps were performed with 200 μl MPBST (5%
milk powder, 0.05% Tween20 in PBS (137 mM NaCl, 2.7
mM KCl, 4.3 mM Na2HPO4, 1.4 mM KH2PO4, pH 7.4))
unless stated otherwise. 96 wells Corning EIA/RIA Micro-
plates were coated overnight at 4°C with 0.5 μg/well (50
μl) GST or BSA in 0.1 M NaHCO3 pH 8.6. After overnight
incubation the plates were washed 3 times with PBS/
0.05% Tween20. Plates were blocked with 50 μl MPBST
for 1 hour at room temperature. After washing the plates
3 times, 50 μl samples of sdAb-aGST-MESNA were loaded
and incubated for 1 hour at room temperature. Plates
were washed 6 times and subsequently incubated with 50
μl mouse Anti-VSV monoclonal antibody (5000× diluted)
for 1 hour. Plates were washed 6 times and subsequently
incubated with 50 μl alkaline HRP-conjugated rabbit anti-
mouse immunoglobulin polyclonal antibody (2500×
diluted), for 1 hour. Plates were washed 6 times and sub-
sequently incubated with 50 μl/well detection solution
(1:1 peroxide buffer (UP)/Tetramethylbenzidine (TMB),
BioMérieux, Boxtel, The Netherlands). Reaction was
stopped after 5 to 10 min with 50 μl 2 M sulfuric acid. The
absorbance was measured at 450 nm in duplicate on a
Thermo multiskan ascent platereader.
Solid phase binding assay with immunomicelles
All washing steps were performed with 200 μl HBS. 96
wells Corning EIA/RIA Microplates were coated overnight
at 4°C with 0.5 μg/well (50 μl) GST or milk powder in
HBS (10 mM HEPES, 135 mM NaCl, pH 7.4). After over-
night incubation the plates were washed 3 times. Plates
were blocked with 50 μl MHBS (5% milk powder in HBS)
for 3 hours at room temperature. After washing the plates
3 times, 50 μl samples of sdAb-aGST micelles were loaded
and incubated for 4 hours at room temperature. Plates
were washed 8 times after which the fluorescence of the
rhodamine-containing micelles was measured in dupli-
cate on a Thermo Fluoroskan Ascent FL plate reader (exci-
tation at 578 nm, emission at 620 nm).
Surface Plasmon Resonance
Sensorgrams were obtained on a Biacore T100 (GE
Healthcare) using a CM5 chip functionalized with GST
using standard EDC/NHS protocols. All binding experi-
ments were performed at 25°C using PBS with 0.05%
Tween-20 (PBST) as running buffer at a flow rate of 30 μL/
min. Samples containing 0–500 nM of sdAb-aGST-
MESNA in PBST were injected on a CM5 chip functional-
ized with GST (160 RU immobilized) for 400 sec, fol-
lowed by a 10 min dissociation phase. Regeneration of the
chip was performed with a 30 s injection of 10 mM
NaOH. Aspecific binding and buffer effects were taken
into account by subtracting the simultaneous response
from a reference surface functionalized with eth-
anolamine.
Ligation of cysteine-functionalized biotin to sdAb-aGST
Cysteine-functionalized biotin was prepared according to
a literature procedure and checked with NMR and LC-MS
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analysis [37]. A reaction mixture was prepared containing
7 μM sdAb-α GST-MESNA in 20 mM sodium phosphate,
0.1 mM EDTA, 0.5 M NaCl, pH 6 to which 1 mM cysteine-
functionalized biotin, 50 mM MPAA and 10 mM tris(2-
carboxyethyl) phosphine hydrochloride (TCEP) were
added. The final pH of the reaction mixture was 5.5. The
reaction was incubated overnight at 20°C and analyzed
using LC-MS analysis.
Ligation of sdAb-αGST to cysteine-functionalized micelles
A mixture of 97.5 mol percent Cys-PEG-DSPE and 2.5 mol
percent rhodamine-DPPE in chloroform was placed in a
vial. After chloroform evaporation the obtained lipid film
was rehydrated in 0.1 M sodium phosphate pH 8.5
([lipid] = 640 μM) with 50 mM MPAA and 10 mM TCEP,
vortexed for 2 min followed by 5 min sonication. SdAb-
aGST-MESNA was added to a final concentration of 50
μM (final pH was 6.7). After overnight incubation at room
temperature the protein micelles were analyzed using
SDS-PAGE to check for complete conversion to the lipi-
dated protein.
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